Anti-thrombotic effect of an heparin-like substance (SP 54) preventing red cell and platelet aggregation
Bicher, H.I.
Arzneimittel-Forschung 20(3): 379-381
1970
ISSN/ISBN: 0004-4172 PMID: 4191806 Document Number: 25548
Document emailed within 1 workday
Related Documents
Chong, B.H.; Pitney, W.R.; Castaldi, P.A. 1982: Heparin-induced thrombocytopenia: association of thrombotic complications with heparin-dependent IgG antibody that induces thromboxane synthesis in platelet aggregation Lancet 2(8310): 1246-1249White, M.M.; Siders, L.; Jennings, L.K.; White, F.L. 1992: The effect of residual heparin on the interpretation of heparin-induced platelet aggregation in the diagnosis of heparin-associated thrombocytopenia Thrombosis and Haemostasis 68(1): 88
Davies, J.A.; Menys, V.C. 1982: Effect of heparin on platelet monolayer adhesion, aggregation and production of malondialdehyde Thrombosis Research 26(1): 31-41
Roubal, Z.; Grimová, J.; Nĕmecek, O.; Cepelák, V. 1972: Effects of nonsteroid anti-inflammatory agents and some dicoumarol derivatives on platelet aggregation, fibrinolysis and stabilization of cell membrane in vitro Acta Universitatis Carolinae. Medica. Monographia 53: 229-235
Ambrus, J.L.; Ambrus, C.M.; Gastpar, H.; Williams, P. 1982: Study of platelet aggregation in vivo. IX. Effect of nafazatrom on in vivo platelet aggregation and spontaneous tumor metastasis Journal of Medicine 13(1-2): 35-47
Duriez, R.; Hainaut, J.; Gérard, J.P.; Didier, A.; Duret, J.C.; Larroque, P.; Bon, J.F.; Fromantin, M. 1972: Active anti-platelet antibodies in the presence of acetyl-salicylic acid. Activity on platelet aggregation and cross reactions Annales de Medecine Interne 123(6): 593-596
Appel, J.Z.; Alwayn, I.P.; Correa, L.E.; Cooper, D.K.; Robson, S.C. 2001: Modulation of platelet aggregation in baboons: implications for mixed chimerism in xenotransplantation. II. The effects of cyclophosphamide on pig peripheral blood progenitor cell-induced aggregation Transplantation 72(7): 1306-1310
Zhang, L.; Zhang, G. 1999: Thrombosis induced by homocysteine does not depend on platelet aggregation or heparin cofactor's antithrombin activity Hunan Yi Ke da Xue Xue Bao 24(4): 309
Williamson, D.; Giuliano, S.; Jackson, S.P. 1999: Platelet adhesion receptors: novel targets for anti-thrombotic therapy Australian and New Zealand Journal of Medicine 29(3): 452-461
Larcan, A.; Stoltz, J.F.; Streiff, F.; Nicolas, A.; Alexandre, P. 1972: Effect of ADP on the filtration pressure of a platelet rich plasma. Correlation with platelet aggregation Comptes Rendus des Seances de la Societe de Biologie et de ses Filiales 166(8): 1065-1066
Charuruks, N.; Krailadsiri, P.; Seghatchian, M.J. 1997: Effect of cold exposure on platelet concentrates: changes in platelet indices and aggregation states Journal of the Medical Association of Thailand 80(1): 56-62
Pindur, G.; Köhler, M.; Heiden, M.; Leipnitz, C.; Rupp, K.H.; Wenzel, E. 1990: Pharmacologic and clinical principles for rational anti-thrombotic preventive treatment with low molecular weight heparin Langenbecks Archiv für Chirurgie. Supplement Ii Verhandlungen der Deutschen Gesellschaft für Chirurgie. Deutsche Gesellschaft für Chirurgie. Kongress 1990: 1149-1155
Mauro, R.; Calatola, P.; Di Donato, F.; Frey, L.; Lettieri, A. 1978: Anti-platelet-aggregation drugs and atherosclerosis Minerva Medica 69(33): 2285-2288
Kappa, J.R.; Horn, M.K.; Fisher, C.A.; Cottrell, E.D.; Ellison, N.; Addonizio, V.P. 1987: Efficacy of iloprost (ZK36374) versus aspirin in preventing heparin-induced platelet activation during cardiac operations Journal of Thoracic and Cardiovascular Surgery 94(3): 405-413
Knudsen, F.; Kristensen, S.D.; Nielsen, A.H.; Ring, T.; Stoffersen, E. 1985: Decreased platelet sensitivity to prostacyclin during hemodialysis: an effect of platelet/heparin interaction? Clinical Nephrology 23(2): 107
Takano, S.; Aikawa, T.; Oishi, T.; Goto, M.; Tamura, O.; Suzuki, T. 1979: Effects of anti-inflammatory drugs on platelet aggregation in rabbits Research Communications in Chemical Pathology and Pharmacology 24(3): 501-514
Gorin, N.C.; Fraitag, B.; Feldman, A.; Vallot, T.; Couturier, J.Y.; Najman, A.; Duhamel, G. 1977: Moschowitz's disease: efficacy of anti-platelet aggregation agents La Nouvelle Presse Medicale 6(42): 3959-3961
Tiozzo, R.; Reggiani, D.; Croce, M.A.; Calandra, S.; Osima, B.; Bianchini, P. 1997: Effect of heparin on cell proliferation: lack of correlation with heparin binding sites on cell membrane Drugs under Experimental and Clinical Research 23(3-4): 103-109
Sakata, T. 2013: New stream for the measurement of anti-platelet factor 4/heparin antibodies Rinsho Byori. Japanese Journal of Clinical Pathology 61(2): 137-143
Yang, Y.; Zuo, J.; Li, J.-m.; Ma, X.-d.; Zhang, Y.-c.; Huang, W.-j. 2017: Design, synthesis, and biological evaluation of phenylpropenamides compounds as anti-platelet aggregation Yao Xue Xue Bao 52(1): 120-125